Tag Archive for ‘rectal cancer’


Organ preservation in rectal adenocarcinoma: The OPRA Trial

The study design of the OPRA Trial, which includes a watch-and-wait cohort for locally advanced rectal cancer, is summarized.

NAPRC program logo

NAPRC awards first accreditation to John Muir Health Rectal Cancer Program

The ACS NAPRC’s first accreditation was awarded to the John Muir Health Rectal Cancer Program in California after meeting 19 standards.


Induction chemotherapy and minimally invasive transanal surgery to increase organ preservation in rectal cancer

The objectives of the NEO Trial (CCTG CO28) are described, specifically the feasibility and safety of induction chemotherapy and minimally invasive transanal surgery to allow sphincter preservation.

Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC

Over the last three decades, there has been a significant shift in cancer care from the generalist to the specialist setting. This shift is especially true in surgical oncology, where surgeons specializing in the care of breast cancer, esophageal cancer, and pancreatic cancer have become the norm for many facilities treating cancer patients in the […]

Figure 1. NRG Oncology NRG-GI002 Schema

NRG GI002: Moving the needle toward TNT in locally advanced rectal cancer

The approach, aims, and eligibility criteria of the NRG Oncology TNT clinical trial are summarized.


Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611


Download the Bulletin App

Apple Store
Get it on Google Play
Amazon store